Copyright
©The Author(s) 2021.
World J Clin Cases. Jul 26, 2021; 9(21): 5840-5849
Published online Jul 26, 2021. doi: 10.12998/wjcc.v9.i21.5840
Published online Jul 26, 2021. doi: 10.12998/wjcc.v9.i21.5840
Group | n | Symptom part | Active part | |||
Before intervention | After intervention | Before intervention | After intervention | |||
1 | Refined care | 61 | 51.4 ± 8.5 | 76.8 ± 9.01 | 44.2 ± 7.4 | 71.9 ± 5.51 |
Control | 59 | 49.2 ± 6.2 | 71.0 ± 7.41 | 45.8 ± 6.6 | 67.7 ± 7.81 | |
t | 1.615 | 3.849 | -1.249 | 3.418 | ||
P value | 0.109 | 0.000 | 0.214 | 0.001 | ||
2 | Disease impact | SGRQ score | ||||
Before intervention | After intervention | Before intervention | After intervention | |||
Refined care | 61 | 47.2 ± 6.1 | 78.5 ± 8.51 | 47.6 ± 6.2 | 75.7 ± 7.51 | |
Control | 59 | 49.4 ± 6.6 | 75.8 ± 7.61 | 48.1 ± 6.8 | 71.5 ± 5.81 | |
t | -1.897 | 1.832 | -0.421 | 3.424 | ||
P value | 0.060 | 0.069 | 0.674 | 0.001 |
- Citation: Na N, Guo SL, Zhang YY, Ye M, Zhang N, Wu GX, Ma LW. Value of refined care in patients with acute exacerbation of chronic obstructive pulmonary disease. World J Clin Cases 2021; 9(21): 5840-5849
- URL: https://www.wjgnet.com/2307-8960/full/v9/i21/5840.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i21.5840